Literature DB >> 386342

Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase.

O O Yoi, D C Seldin, J Spragg, G S Pinkus, K F Austen.   

Abstract

A pancreatic endopeptidase localized to the beta-cells of the pancreas by immunohistochemical techniques has been purified to homogeneity by following its functional and antigenic characteristics as a glandular kallikrein (EC 3.4.21.8). The enzyme gave a single stained band on alkaline disc gel electrophoresis which corresponded in location with the kinin-generating activity eluted from a replicate gel, was of 54,000 molecular weight by gel filtration, was devoid of caseinolytic activity, elicited a monospecific antiserum in a rabbit, and gave a line of complete identity with a single constituent in pancreatic extract, crude urine, and purified urokallikrein when analyzed with monospecific antibody to urokallikrein. The pancreatic glandular kallikrein generated three cleavage products of increasing anodal mobility from bovine and porcine proinsulin, and the presence of pancreatic kininase or bovine carboxypeptidase B increased the quantity of these products. Although the conversion products did not correspond to diarginyl- and monoarginylinsulin, the product of intermediate mobility was also obtained when proinsulin was treated with a low concentration of trypsin in the presence of kininase. The most rapidly migrating product did correspond to desalanylinsulin in the reference standard. Kininase alone had no action on proinsulin, and aprotinin prevented cleavage by kallikrein alone or in combination with kininase. Although the chemical structure of the proinsulin cleavage products has not been established, human pancreatic kallikrein is considered a putative activator of proinsulin because of its location in the beta-cell, its preferential action on proinsulin and kininogen as compared to azocasein, and its capacity to generate insulin intermediate products that are further modified by human pancreatic kininase or bovine carboxypeptidase B.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 386342      PMCID: PMC383882          DOI: 10.1073/pnas.76.8.3612

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Investigation of serum trypsin and related substances. I. The quantitative demonstration of trypsinlike activity in human blood serum by a micromethod.

Authors:  A M SIEGELMAN; A S CARLSON; T ROBERTSON
Journal:  Arch Biochem Biophys       Date:  1962-04       Impact factor: 4.013

3.  The nature of the kallidins released from human plasma by kallikreins and other enzymes.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

4.  Studies on the conversion of proinsulin to insulin. 3. Studies in vitro with a crude secretion granule fraction isolated from rat islets of Langerhans.

Authors:  W Kemmler; D F Steiner; J Borg
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

Review 5.  Proteolytic processing in the biosynthesis of insulin and other proteins.

Authors:  D F Steiner; W Kemmler; H S Tager; J D Peterson
Journal:  Fed Proc       Date:  1974-10

6.  Isolation of two functionally different kininogens from human plasma--separation from proteinase inhibitors and interaction with plasma kallikrein.

Authors:  F M Habal; H Z Movat; C E Burrowes
Journal:  Biochem Pharmacol       Date:  1974-08-15       Impact factor: 5.858

7.  Inhibition of human urinary kallikrein (urokallikrein) by anti-enzyme FAB.

Authors:  O K ole-MoiYoi; J Spragg; K F Austen
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

8.  Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes.

Authors:  J K Czop; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

9.  Immunologic reactivity of purified human urinary kallikrein (urokallikrein) with antiserum directed against human pancreas.

Authors:  O ole-Moi Yoi; J Spragg; S P Halbert; K F Austen
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

10.  Localization of kallikrein and its relation to other trypsin-like esterases in the rat pancreas. A comparison with the submandibular gland.

Authors:  T B Orstavik; G G Glenner
Journal:  Acta Physiol Scand       Date:  1978-08
View more
  17 in total

Review 1.  Secretory granules.

Authors:  J C Hutton
Journal:  Experientia       Date:  1984-10-15

Review 2.  Multiple forms of gastroenteropancreatic hormones.

Authors:  G B Irvine; R F Murphy
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

3.  Identification and characterization of a tissue kallikrein in rat skeletal muscles.

Authors:  N Shimojo; J Chao; L Chao; H S Margolius; R K Mayfield
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

Review 4.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 5.  Pituitary endopeptidases.

Authors:  M Orlowski
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

6.  Identification of a 31,500 molecular weight islet cell protease as cathepsin B.

Authors:  K Docherty; R Carroll; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  The role of glandular kallikrein in the formation of a salivary proline-rich protein A by cleavage of a single bond in salivary protein C.

Authors:  R S Wong; G Madapallimattam; A Bennick
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

8.  Proteolytic conversion of proinsulin into insulin. Identification of a Ca2+-dependent acidic endopeptidase in isolated insulin-secretory granules.

Authors:  H W Davidson; M Peshavaria; J C Hutton
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

9.  Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.

Authors:  M Maier; K F Austen; J Spragg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

10.  Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.

Authors:  N B Oza; J H Schwartz; H D Goud; N G Levinsky
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.